Medicare Rx Card Fraud Rule
This article was originally published in The Pink Sheet Daily
Executive Summary
The HHS Office of Inspector General has finalized a rule governing imposition of civil monetary penalties against Medicare-endorsed drug discount card sponsors that engage in prohibited practices
You may also be interested in...
Medicare Rx Card Fraud Rule Sets Penalties For Marketing Violations
An interim final rule providing for civil monetary penalties that may be imposed against Medicare-endorsed card sponsors is scheduled for publication May 19.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
One Trial Plus Supportive Evidence Is Enough For Hospital-, Ventilator-Acquired Pneumonia Indication, Panel Says
Anti-Infective Drugs Advisory Committee members viewed one-trial as practical means of gaining efficacy data.